5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
about
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@en
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@nl
type
label
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@en
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@nl
prefLabel
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@en
5-(4,6-Dimorpholino-1,3,5-tria ...... linical Candidate in Oncology.
@nl
P2093
P2860
P50
P1476
5-(4,6-Dimorpholino-1,3,5-tria ...... Clinical Candidate in Oncology
@en
P2093
Anna Melone
Bernd Giese
Denise Rageot
Doriano Fabbro
Eileen Jackson
Florent Beaufils
Jürgen Mestan
Natasa Cmiljanovic
Paul Hebeisen
Petra Hillmann
P2860
P304
P356
10.1021/ACS.JMEDCHEM.7B00930
P407
P577
2017-09-01T00:00:00Z